Louis Lange

Person

Palo Alto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method and composition for inhibiting human cholesterol esterase
- Patent number 6,632,801
- Issue date Oct 14, 2003
- CV Therapeutics, Inc.
- Louis G. Lange
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Methods and reagents for RFLP analysis of the human pancreatic chol...
- Patent number 6,107,026
- Issue date Aug 22, 2000
- Louis G. Lange
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Macrophage lipid chemoattractant
- Patent number 5,869,537
- Issue date Feb 9, 1999
- CV Therapeutics
- George F. Schreiner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides from mammalian pancreatic cholesterol esterase
- Patent number 5,792,832
- Issue date Aug 11, 1998
- Louis George Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating ulcers with sulfated polysaccharides
- Patent number 5,679,375
- Issue date Oct 21, 1997
- C.V. Therapeuctics
- Curtis A. Spilburg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrophage lipid chemoattractant
- Patent number 5,663,450
- Issue date Sep 2, 1997
- CV Therapeutics
- George F. Schreiner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding bovine pancreatic cholesterol esterase
- Patent number 5,624,836
- Issue date Apr 29, 1997
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of non-absorbable synthetic sulfated polysaccharides to decreas...
- Patent number 5,616,570
- Issue date Apr 1, 1997
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of manufacturing non-absorbable synthetic sulfated polysacch...
- Patent number 5,521,303
- Issue date May 28, 1996
- CV Therapeutics, Inc.
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for recovering purified 100,000 dalton molecular weight frac...
- Patent number 5,492,822
- Issue date Feb 20, 1996
- Lange, III; Louis G.
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pancreatic cholesterol esterase inhibitor
- Patent number 5,484,777
- Issue date Jan 16, 1996
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for measuring human cholesterol absorption using metabolical...
- Patent number 5,432,058
- Issue date Jul 11, 1995
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for recovering purified 100,000 molecular weight fraction of...
- Patent number 5,429,937
- Issue date Jul 4, 1995
- CV Therapeutics
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for recovering purified 52,000 dalton fraction of human panc...
- Patent number 5,352,601
- Issue date Oct 4, 1994
- Lange, III; Louis G.
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mammalian pancreatic cholesterol esterase
- Patent number 5,173,408
- Issue date Dec 22, 1992
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of sulfated polysaccharides to decrease cholesterol and fatty a...
- Patent number 5,063,210
- Issue date Nov 5, 1991
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of sulfated polysaccharides to inhibit pancreatic cholesterol e...
- Patent number 5,017,565
- Issue date May 21, 1991
- Louis G. Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPY FOR PREVENTING ADDICTION
- Publication number 20200237789
- Publication date Jul 30, 2020
- Amygdala Neurosciences, Inc.
- Brent Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
- Publication number 20100035890
- Publication date Feb 11, 2010
- Gilead Palo Alto, Inc.
- Louis Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
- Publication number 20090312340
- Publication date Dec 17, 2009
- Whedy Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
- Publication number 20090111826
- Publication date Apr 30, 2009
- Louis Lange
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Louis Lange

Person

Patents Grantslast 30 patents

Method and composition for inhibiting human cholesterol esterase

Methods and reagents for RFLP analysis of the human pancreatic chol...

Macrophage lipid chemoattractant

Peptides from mammalian pancreatic cholesterol esterase

Method of treating ulcers with sulfated polysaccharides

Macrophage lipid chemoattractant

DNA encoding bovine pancreatic cholesterol esterase

Use of non-absorbable synthetic sulfated polysaccharides to decreas...

Method of manufacturing non-absorbable synthetic sulfated polysacch...

Method for recovering purified 100,000 dalton molecular weight frac...

Pancreatic cholesterol esterase inhibitor

Method for measuring human cholesterol absorption using metabolical...

Method for recovering purified 100,000 molecular weight fraction of...

Method for recovering purified 52,000 dalton fraction of human panc...

Mammalian pancreatic cholesterol esterase

Use of sulfated polysaccharides to decrease cholesterol and fatty a...

Use of sulfated polysaccharides to inhibit pancreatic cholesterol e...

Patents Applicationslast 30 patents

COMBINATION THERAPY FOR PREVENTING ADDICTION

USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES